CEP-40783
| CAS No. | 1437321-24-8 | Cat. No. | BCP25839 |
| Name | CEP-40783 | ||
| Synonyms | CEP40783; CEP 40783; RXDX-106; RXDX 106; RXDX106; | ||
| Formula | C31H26F2N4O6 | M. Wt | 588.56 |
| Description | CEP-40783, also known as RXDX-106, is a potent, selective and orally available inhibitor of AXL and c-Met with IC50 values of 7 nM and 12 nM, respectively for use in breast, non-small cell lung (NSCLC), and pancreatic cancers. | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase | ||
| Targets | TAM Receptor c Met | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.